6. Glycemic Targets
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Two primary techniques are available for health providers and patients to assess the effectiveness of the management plan on glycemic control: patient self-monitoring of blood glucose (SMBG) or interstitial glucose and A1C.Continuous glucose monitoring (CGM) may be a useful adjunct to SMBG in selected patients.Recommendations c When prescribed as part of a broader educational context, SMBG results may help guide treatment decisions and/or self-management for patients using less frequent insulin injections B or noninsulin therapies.E c When prescribing SMBG, ensure that patients receive ongoing instruction and regular evaluation of SMBG technique, SMBG results, and their ability to use SMBG data to adjust therapy.E c Patients on multiple-dose insulin or insulin pump therapy should perform SMBGprior to meals and snacks, occasionally postprandially, at bedtime, prior to exercise, when they suspect low blood glucose, after treating low blood glucose until they are normoglycemic, and prior to critical tasks such as driving.B c When used properly, CGM in conjunction with intensive insulin regimens is a useful tool to lower A1C in selected adults (aged $25 years) with type 1 diabetes.A c Although the evidence for A1C lowering is less strong in children, teens, and younger adults, CGM may be helpful in these groups.Success correlates with adherence to ongoing use of the device.B c CGM may be a supplemental tool to SMBG in those with hypoglycemia unawareness and/or frequent hypoglycemic episodes.C c Given variable adherence to CGM, assess individual readiness for continuing use of CGM prior to prescribing.E c When prescribing CGM, robust diabetes education, training, and support are required for optimal CGM implementation and ongoing use.E Suggested citation: American Diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the evidence that monitoring alone improves symptom control [30], in our review we sought to understand the contribution an intervention involving an app can make.”
From The effectiveness of self-management mobile phone and tablet apps in long-term condition management: a systematic review (2016) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“eral months (3) and has strong predictive value for diabetes complications (22,23).”
BackgroundEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“Long-term follow-up of the UKPDS cohorts showed enduring effects of early glycemic control on most microvascular complications (34).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079 · cited 2×
“The Kumamoto Study (31) and UK Prospective Diabetes Study (UKPDS) (32,33) confirmed that intensive”
Background
Cited by
Whitehead, L., & Seaton, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4883 · Cited by 743
Glycemic Variability: How Do We Measure It and Why Is It Important?
Suh, S., & Kim, J. H. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.273 · Cited by 439
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions
Rickels, M. R., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00154 · Cited by 329
Rodríguez-Gutiérrez, R., & Montori, V. M. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.002901 · Cited by 176
Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes
Weinstock, R. S., DuBose, S. N., Bergenstal, R. M., Chaytor, N. S., Peterson, C., Olson, B. A., Munshi, M. N., Perrin, A. J. S., Miller, K. M., Beck, R. W., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1426 · Cited by 171
Oris, L., Rassart, J., Prikken, S., Verschueren, M., Goubert, L., Moons, P., Berg, C. A., Weets, I., & Luyckx, K. (2016) · Diabetes Care · doi:10.2337/dc15-2559 · Cited by 166
Management of diabetes mellitus in patients with chronic kidney disease
Hahr, A. J., & Molitch, M. E. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0001-9 · Cited by 142
Bae, J. P., Lage, M. J., Mo, D., Nelson, D. R., & Hoogwerf, B. J. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.016 · Cited by 136
Kumar, R. B., Goren, N. D., Stark, D. E., Wall, D. P., & Longhurst, C. A. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv206 · Cited by 126
Afroz, A., Ali, L., Karim, M. N., Alramadan, M. J., Alam, K., Magliano, D. J., & Billah, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-46766-9 · Cited by 121
Bergenstal, R. M., Bailey, T. S., Rodbard, D., Ziemen, M., Guo, H., Muehlen-Bartmer, I., & Ahmann, A. J. (2017) · Diabetes Care · doi:10.2337/dc16-0684 · Cited by 122
Glycemic Control and the Risk of Tuberculosis: A Cohort Study
Lee, P.-H., Fu, H., Lai, T.-C., Chiang, C., Chan, C., & Lin, H.-H. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002072 · Cited by 142
Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
Zhang, Z., Miao, L.-F., Qian, L., Wang, N., Qi, M., Zhang, Y., Dang, S., Wu, Y., & Wang, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00640 · Cited by 119
Yigazu, D. M., & Desse, T. A. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2924-y · Cited by 97
Ahn, C. H., Min, S. H., Lee, D.-H., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., Ha, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00191 · Cited by 91
Diabetes Care in Iran: Where We Stand and Where We Are Headed
Noshad, S., Afarideh, M., Heidari, B., Mechanick, J. I., & Esteghamati, A. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2015.10.003 · Cited by 91
Role of Amylin in Type 1 and Type 2 Diabetes
Hieronymus, L., & Griffin, S. (2015) · The Diabetes Educator · doi:10.1177/0145721715607642 · Cited by 86
Avoidant coping and diabetes-related distress: Pathways to adolescents’ Type 1 diabetes outcomes.
Iturralde, E., Weissberg-Benchell, J., & Hood, K. K. (2017) · Health Psychology · doi:10.1037/hea0000445 · Cited by 83
Johnston, R., Uthman, O. A., Cummins, E., Clar, C., Royle, P., Colquitt, J. L., Tan, B. K., Clegg, A. J., Shantikumar, S., Court, R. A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21020 · Cited by 91
Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
Silverstein, J. M. (2016) · Pituitary · doi:10.1007/s11102-016-0734-1 · Cited by 83
Ziegler, D., Low, P. A., Freeman, R. L., Tritschler, H., & Vinik, A. I. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.10.018 · Cited by 89
Parenting and Treatment Adherence in Type 1 Diabetes Throughout Adolescence and Emerging Adulthood
Goethals, E. R., Oris, L., Soenens, B., Berg, C. A., Prikken, S., Broeck, N. V., Weets, I., Casteels, K., & Luyckx, K. (2017) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx053 · Cited by 85
Wu, I. X. Y., Kee, J. C. Y., Threapleton, D. E., Ma, R. C. W., Lam, V. C. K., Lee, E. K. P., Wong, S. Y. S., & Chung, V. C. H. (2018) · Obesity Reviews · doi:10.1111/obr.12669 · Cited by 71
Crowley, M. J., Edelman, D., McAndrew, A. T., Kistler, S., Danus, S., Webb, J. A., Zanga, J., Sanders, L. L., Coffman, C. J., Jackson, G. L., et al. (2016) · Telemedicine and e-Health · doi:10.1089/tmj.2015.0145 · Cited by 68
Lu, C.-L., Shen, H.-N., Hu, S. C., Wang, J.-D., & Li, C.-Y. (2016) · Diabetes Care · doi:10.2337/dc15-2418 · Cited by 66
Yoon, Y.-S., Jung, J., Jeon, E. J., Seo, H., Ryu, Y. J., Yim, J., Kim, Y. H., Lee, B.-H., Park, Y. B., Lee, B. J., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207686 · Cited by 63
Zhang, Y., Liu, W., Liu, D., Zhao, T.-Y., & Tian, H. (2016) · Nutrients · doi:10.3390/nu8070388 · Cited by 80
A Review of Safety and Design Requirements of the Artificial Pancreas
Blauw, H., Keith-Hynes, P., Koops, R., & DeVries, J. H. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1679-2 · Cited by 75
Zhong, V. W., Juhaeri, J., Cole, S. R., Kontopantelis, E., Shay, C. M., Gordon-Larsen, P., & Mayer-Davis, E. J. (2017) · Diabetes Care · doi:10.2337/dc16-2680 · Cited by 62
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Guo, L., & Xiao, X. (2024) · Aging Medicine · doi:10.1002/agm2.12294 · Cited by 78
Okamoto, A., Yokokawa, H., Sanada, H., & Naito, T. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0137-9 · Cited by 59
Rickels, M. R., Peleckis, A. J., Markmann, E., Dalton-Bakes, C., Kong, S. M., Teff, K. L., & Naji, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1649 · Cited by 60
Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
Rhee, S. Y., & Kim, Y. S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.283 · Cited by 76
Self-efficacy, depression and self-care activities of people with type 2 diabetes in Turkey
Kav, S., Yılmaz, A., Bulut, Y., & Doğan, N. (2015) · Collegian Journal of the Royal College of Nursing Australia · doi:10.1016/j.colegn.2015.09.005 · Cited by 72
Sajatovic, M., Gunzler, D. D., Kanuch, S. W., Cassidy, K. A., Tatsuoka, C., McCormick, R., Blixen, C. E., Perzynski, A. T., Einstadter, D., Thomas, C. L., et al. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600377 · Cited by 55
Tankova, T. I., Senkus, E., Beloyartseva, M., Borštnar, S., Catrinoiu, D., Фролова, М. А., Hegmane, A., Janež, A., Krnić, M., Lengyel, Z., et al. (2022) · Cancers · doi:10.3390/cancers14071598 · Cited by 65
Gandhi, K. K., Vu, B.-M. K., Eshtehardi, S. S., Wasserman, R. M., & Hilliard, M. E. (2015) · Diabetes Management · doi:10.2217/dmt.15.41 · Cited by 60
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?
Giorgino, F., Home, P. D., & Tuomilehto, J. (2016) · Diabetes Care · doi:10.2337/dcs15-3023 · Cited by 54
Honda, H., Igaki, M., Hatanaka, Y., Komatsu, M., Tanaka, S.-I., Miki, T., Suzuki, T., Takaishi, T., & Hayashi, T. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000232 · Cited by 50
Versteeg, R. I., Stenvers, D. J., Visintainer, D., Linnenbank, A. C., Tanck, M. W. T., Zwanenburg, G., Smilde, A. K., Fliers, E., Kalsbeek, A., Serlie, M. J. M., et al. (2017) · Journal of Biological Rhythms · doi:10.1177/0748730417693480 · Cited by 52
Luyckx, K., Verschueren, M., Palmeroni, N., Goethals, E. R., Weets, I., & Claes, L. (2019) · Diabetes Care · doi:10.2337/dc19-0445 · Cited by 49
Cardiovascular health in adults with type 1 diabetes
McCarthy, M. M., Funk, M., & Grey, M. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.019 · Cited by 48
Russell-Jones, D. L., Dauchy, A., Delgado, E., Dimitriadis, G., Frandsen, H., Popescu, L., Schultes, B., Strojek, K., Bonnemaire, M., de Climens, A. R., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13697 · Cited by 45
Nadkarni, G. N., & Vassalotti, J. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-24687-1_28 · Cited by 39
Haymond, M. W., Redondo, M. J., McKay, S., Cummins, M. J., Newswanger, B., Kinzell, J., & Prestrelski, S. (2016) · Diabetes Care · doi:10.2337/dc15-2124 · Cited by 39
The Role of Glycemic Control and Variability in Diabetic Retinopathy
Chatziralli, I. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0345-5 · Cited by 41
Yang, A., Wu, H., Lau, E. S. H., Zhang, X., Shi, M., Fan, B., Ronald, C. W., Kong, A. P. S., Luk, A. O. Y., Chan, J. C. N., et al. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100509 · Cited by 44
Hyperglycemia and Diabetes Mellitus Following Organ Transplantation
Galindo, R. J., & Wallia, A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0707-1 · Cited by 39
Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes
Merchant, A. T., Georgantopoulos, P., Howe, C. J., Virani, S. S., Morales, D., & Haddock, K. S. (2015) · Journal of Dental Research · doi:10.1177/0022034515622197 · Cited by 35
Lu, C., Chang, Y., Sun, Y., & Li, C. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.020 · Cited by 36
Javaid, Z., Imtiaz, U., Khalid, I. M., Saeed, H., Khan, R. Q., Islam, M. F., Saleem, Z., Sohail, M. F., Danish, Z., Batool, F., et al. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4274-z · Cited by 40
Gordon, I., Rutherford, C., Makarounas‐Kirchmann, K., & Kirchmann, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108158 · Cited by 40
Kwon, C. S., Seoane-Vazquez, E. C., & Rodríguez-Monguió, R. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-2860-0 · Cited by 39
Diabetes and obesity and risk of pyogenic liver abscess
Wang, J., Hsu, C., Wu, C.-Y., & Lin, H.-H. (2023) · Scientific Reports · doi:10.1038/s41598-023-34889-z · Cited by 37
“Diabetes with good control was defined as FPG ≤ 130 mg/dL, while diabetes with poor control was defined as FPG > 130 mg/ dL 24 .”
Park, J. I., Bae, E., Kim, Y.-L., Kang, S., Yang, C. W., Kim, N., Lee, J. P., Kim, D. K., Joo, K. W., Kim, Y. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136085 · Cited by 30
Afsharian, S., Akbarpour, S., Abdi, H., Sheikholeslami, F. H., Moeini, A. S. H., Khalili, D., Momenan, A. A., Azizi, F., & Hadaegh, F. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2776 · Cited by 31
Saxagliptin: A Review in Type 2 Diabetes
Dhillon, S. (2015) · Drugs · doi:10.1007/s40265-015-0473-z · Cited by 37
Lee, M. J., Kwon, Y. E., Park, K. S., Kee, Y. K., Yoon, C.-Y., Han, I. M., Han, S. G., Oh, H. J., Park, J. T., Han, S. H., et al. (2016) · Medicine · doi:10.1097/md.0000000000003118 · Cited by 32
Moazzeni, S. S., Arani, R. H., Hasheminia, M., Tohidi, M., Azizi, F., & Hadaegh, F. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0109 · Cited by 33
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes
Ahn, D. T., Pettus, J., & Edelman, S. V. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816632241 · Cited by 31
Insulin Therapy: A Personal Approach
Davidson, M. B. (2015) · Clinical Diabetes · doi:10.2337/diaclin.33.3.123 · Cited by 33
Dagogo-Jack, S. (2015) · Diabetes Care · doi:10.2337/dc15-0533 · Cited by 28
Influence of iron deficiency on Hb A1c levels in type 2 diabetic patients
Urrechaga, E. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.06.024 · Cited by 30
Association of Genomic Instability with HbA1c levels and Medication in Diabetic Patients
Grindel, A., Brath, H., Nersesyan, A. K., Knasmüller, S., & Wagner, K. (2017) · Scientific Reports · doi:10.1038/srep41985 · Cited by 27
Li, J., Gordon, S. C., Rupp, L. B., Zhang, T., Trudeau, S., Holmberg, S. D., Moorman, A. C., Spradling, P. R., Teshale, E. H., Boscarino, J. A., et al. (2018) · Liver International · doi:10.1111/liv.14031 · Cited by 27
Shimels, T., Abebaw, M., Bilal, A. I., & Tesfaye, T. (2018) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v28i4.12 · Cited by 28
Weng, W., Tian, Y., Kimball, E. S., Kong, S. X., Bouchard, J. R., Hobbs, T. M., & Sakurada, B. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000382 · Cited by 27
Hyperglycemia management in patients with posttransplantation diabetes
Galindo, R. J., Fried, M., Breen, T., & Tamler, R. (2016) · Endocrine Practice · doi:10.4158/ep151039.ra · Cited by 25
Nagayama, D., Watanabe, Y., Yamaguchi, T., Saiki, A., Shirai, K., & Tatsuno, I. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120958625 · Cited by 29
Educational attainment moderates the associations of diabetes education with health outcomes
Kim, S. H. (2016) · International Journal of Nursing Practice · doi:10.1111/ijn.12454 · Cited by 33
Mosca, A., Paleari, R., Carobene, A., Weykamp, C. W., & Ceriotti, F. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.014 · Cited by 24
Cambra, K., Galbete, A., Forga, L., Lecea, Ó., Ariz, M. J., Moreno-Iribas, C., Aizpuru, F., & Ibáñez, B. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0533-9 · Cited by 25
Moazzeni, S. S., Arani, R. H., Deravi, N., Hasheminia, M., Khalili, D., Azizi, F., & Hadaegh, F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01326-2 · Cited by 26
Argento, N. B., & Nakamura, K. (2015) · Endocrine Practice · doi:10.4158/ep151016.or · Cited by 23
de Souza, K. S. C., Ururahy, M. A. G., Oliveira, Y. M. D. C., Loureiro, M. B., da Silva, H. P. V., Bortolin, R. H., dos Santos, F. M., Luchessi, A. D., Neto, J. J. M., Arrais, R. F., et al. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2772 · Cited by 29
Hirsch, A. G., Durden, T. E., Nordberg, C. M., Berger, A. L., & Schwartz, B. S. (2017) · Diabetes Care · doi:10.2337/dc17-1200 · Cited by 25
Peripheral Arterial Disease: A Narrative Review
Parwani, D., Ahmed, M. A., Mahawar, A., & Gorantla, V. R. (2023) · Cureus · doi:10.7759/cureus.40267 · Cited by 43
Vejle Diabetes Biobank – a resource for studies of the etiologies of diabetes and its comorbidities
Petersen, E. R. B., Nielsen, A. A., Christensen, H., Hansen, T. F., Pedersen, O. B., Christensen, C., & Brandslund, I. (2016) · Clinical Epidemiology · doi:10.2147/clep.s113419 · Cited by 22
Co-Existing Prostate Cancer and Diabetes Mellitus: Implications for Patient Outcomes and Care
Karlin, N. J., Amin, S. B., Verona, P. M., Kosiorek, H., & Cook, C. B. (2017) · Endocrine Practice · doi:10.4158/ep161702.or · Cited by 22
Zhong, V. W., Juhaeri, J., Cole, S. R., Shay, C. M., Gordon‐Larsen, P., Kontopantelis, E., & Mayer‐Davis, E. J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.008 · Cited by 23
“…Diabetes management strategies have been recently shifted from emphasizing hyperglycemia control to recommending individualized glycemic targets, 31,32 particularly after the three milestone cardiovascular trials in T2D 33 – 35 ; ii) New drugs have become available for treating T2D such as…”
Backgroundda Silva, B. R., Cirelli, T., Nepomuceno, R., Theodoro, L. H., Orrico, S. R. P., Cirelli, J. A., Barros, S. P., & Scarel‐Caminaga, R. M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.08.036 · Cited by 25
Grunberger, G., Bailey, T. S., Camacho, P. M., EINHORN, D. F., Garber, A. J., Handelsman, Y., Harrell, R. M., Lando, H. M., Law, B., Leffert, J. D., et al. (2015) · Endocrine Practice · doi:10.4158/ep15653.cs · Cited by 22
The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes
Paty, B. W. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.009 · Cited by 26
Individualised treatment targets in patients with type-2 diabetes and hypertension
for the DIALOGUE study group, Schmieder, R. E., Tschöpe, D., Koch, C., Ouarrak, T., & Gitt, A. K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0661-8 · Cited by 23
Anemia in diabetes: Experience of a single treatment center in Kuwait
Alsayegh, F., Waheedi, M., Bayoud, T., Alhubail, A., Al-Refaei, F. H., & Sharma, P. M. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.04.002 · Cited by 23
Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy
Brugnara, L., Mallol, R., Ribalta, J., Vinaixa, M., Murillo, S., Casserras, T., Guardiola, M., Vallvé, J.-C., Kalko, S. G., Correig, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136348 · Cited by 25
Pharmacologic Therapy of Type 2 Diabetes
Wright, J. J., & Tylee, T. S. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.03.014 · Cited by 25
Community to clinic navigation to improve diabetes outcomes
Schoenberg, N. E., Ciciurkaite, G., & Greenwood, M. K. (2016) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2016.11.015 · Cited by 22
Hypoglycemia and diabetes: increased need for awareness
Shaefer, C. F., Hinnen, D., & Sadler, C. E. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1163255 · Cited by 22
Ali, H. S., Kamel, M. M., Agwa, S. H. A., Abdel-Hakeem, M. S., El‐Meteini, M., & Matboli, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1131171 · Cited by 19
Munch, L., Arreskov, A. B., Sperling, M., Overgaard, D., Knop, F. K., Vilsbøll, T., & Røder, M. E. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1365-y · Cited by 20
Ahn, S., Lee, J., Bartlett-Prescott, J., Carson, L., Post, L., & Ward, K. D. (2017) · American Journal of Health Promotion · doi:10.1177/0890117117696250 · Cited by 21
Identity formation in adolescents and emerging adults with type 1 diabetes
Verschueren, M., Oris, L., Claes, L., Moons, P., Weets, I., & Luyckx, K. (2019) · Psychology Health & Medicine · doi:10.1080/13548506.2019.1653482 · Cited by 24
Rao, J., Singh, K., Afsheen, T., & Tiwari, B. (2019) · Indian Journal of Dental Research · doi:10.4103/ijdr.ijdr_606_17 · Cited by 21
The clinical potential of low-level C-peptide secretion
Ludvigsson, J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1210513 · Cited by 20
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
Thompson, G., & Hershon, K. S. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s100288 · Cited by 21
Diabetes Mellitus: An Overview
Abutaleb, M. (2016) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2016.04.00087 · Cited by 25
Ambulatory glucose profile (AGP): utility in UK clinical practice
Evans, M. L., CRANSTON, I. C., & Bailey, C. J. (2017) · British Journal of Diabetes · doi:10.15277/bjd.2017.121 · Cited by 19
Feinberg, T., Wieland, L. S., Miller, L. E., Munir, K. M., Pollin, T. I., Shuldiner, A. R., Amoils, S., Gallagher, L., Bahr-Robertson, M. K., & D’Adamo, C. R. (2019) · Trials · doi:10.1186/s13063-018-3032-6 · Cited by 21
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-12-17
- Volume
- 38
- Issue
- Supplement_1
- Pages
- S33-S40
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4241059420
- Cited by
- 205
- References
- 58
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 22 · 2018: 15 · 2017: 37 · 2016: 59 · 2015: 34 · 2014: 1
- FWCI
- 35.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glycemic control, glycemic targets, self-monitoring of blood glucose, continuous glucose monitoring, HbA1c, type 1 diabetes, hypoglycemia, hypoglycemia unawareness, diabetes self-management education, insulin therapy, device adherence
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Patient Care Planning, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.